Extension of Time to File SOU

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1581 (Rev 09/2005)

OMB No. 0651-0054 (Exp 12/31/2020)

---

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1581 (Rev 09/2005)

OMB No. 0651-0054 (Exp 12/31/2020)

SOU Extension Request
(15 U.S.C. Section 1051(d))

To the Commissioner for Trademarks:

MARK: ZYREXAL (see, http://uspto.report/TM/88166503/mark.png)
SERIAL NUMBER: 88166503

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Vivera Pharmaceuticals, Inc., having an address of
      4533 MacArthur Blvd., #5049
      Newport Beach, California 92660
      United States
      Email: XXXX
Proposed: Vivera Pharmaceuticals, Inc., having an address of
      4533 MacArthur Blvd., #5049
      Newport Beach, California 92660
      United States
      Phone:
      Fax:
      Email: XXXX

The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 08/27/2019.

For International Class 005:
Current identification: Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of prescription dosage capsules that facilitate the delivery of pharmaceutical preparations; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; all of the foregoing excluding pharmaceutical preparations and substances for the treatment of the central nervous system, sleep disorders, and neurological diseases or disorders

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the second extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension request: product or service research or development

Correspondence Information (current):
      Stephen J. Straus
      PRIMARY EMAIL FOR CORRESPONDENCE: ipdocket@buchalter.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): sstrauss@buchalter.com; aharvey@buchalter.com

Correspondence Information (proposed):
      Stephen J. Straus
      PRIMARY EMAIL FOR CORRESPONDENCE: ipdocket@buchalter.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): sstrauss@buchalter.com; aharvey@buchalter.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).





A fee payment in the amount of $125 will be submitted with the form, representing payment for 1 class.


Declaration



Original PDF file:
hw_3810653100-222342089_. _zyrexal_-_ext.pdf
Converted PDF file(s) (1 page)
Signature File1

Signatory's Name: Olivia Karpinski
Signatory's Position: Director

RAM Sale Number: 88166503
RAM Accounting Date: 08/27/2020

Serial Number: 88166503
Internet Transmission Date: Thu Aug 27 22:27:06 ET 2020
TEAS Stamp: USPTO/ESU-XX.XXX.XX.XXX-2020082722270644
8749-88166503-740face3d9b8facd9a297286e3
f35bc12ff2e19c4e4a6c14b94248290299d52362
f-DA-27047522-20200827222342089526